Stock Events

Stock Events

Scinai Immunotherapeutics 

€0.48
17
+€0.01+1.27% Wednesday 07:16

Statistics

Day High
0.48
Day Low
0.48
52W High
4.98
52W Low
0.47
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

691.02%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.25MRevenue
8.64MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2F5.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Show more...
CEO
ISIN
US09073Q3039
WKN
000A40DEH

Listings

F
DE
2F5.F
XNAS
US
SCNI
BOATS
BOATS
SCNI.BOATS

0 Comments

Share your thoughts

FAQ

What is Scinai Immunotherapeutics stock price today?▼
The current price of 2F5.F is €0.48 EUR — it has increased by +1.27% in the past 24 hours. Watch Scinai Immunotherapeutics stock price performance more closely on the chart.
What is Scinai Immunotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scinai Immunotherapeutics stocks are traded under the ticker 2F5.F.
Is Scinai Immunotherapeutics stock price growing?▼
2F5.F stock has fallen by -13.87% compared to the previous week, the month change is a -32.2% fall, over the last year Scinai Immunotherapeutics has showed a -81.03% decrease.
What is Scinai Immunotherapeutics revenue for the last year?▼
Scinai Immunotherapeutics revenue for the last year amounts to 1.25M EUR.
What is Scinai Immunotherapeutics net income for the last year?▼
2F5.F net income for the last year is 8.64M EUR.
When did Scinai Immunotherapeutics complete a stock split?▼
The last stock split for Scinai Immunotherapeutics was on May 21, 2024 with a ratio of 1:10.